|
|
Volumn 14, Issue 4, 2007, Pages
|
|
Food and Drug Administration Public Hearing on the Draft Guidance for Exception from Informed Consent Requirements for Emergency Research: Testimony of Novo Nordisk
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
CLINICAL PHARMACY;
CLINICAL RESEARCH;
EMERGENCY MEDICINE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INFORMED CONSENT;
LAW;
MEDICAL ETHICS;
PATIENT RIGHT;
PRIORITY JOURNAL;
UNITED STATES;
|
|
EID: 34047125243
PISSN: 10696563
EISSN: None
Source Type: Journal
DOI: 10.1197/j.aem.2006.12.001 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
